Background. Rubinstein-Taybi syndrome (RSTS) is a congenital neurodevelopmental disorder defined by postnatal growth deficiency, characteristic skeletal abnormalities and mental retardation and caused by mutations in the genes encoding for the transcriptional co-activators with intrinsic lysine acetyltransferase (KAT) activity CBP and p300. Previous studies have shown that neuronal histone acetylation is reduced in mouse models of RSTS. Methods. The authors identified different mutations at the CREBBP locus and generated lymphoblastoid cell lines derived from nine patients with RSTS carrying distinct CREBBP mutations that illustrate different grades of the clinical severity in the spectrum of the syndrome. They next assessed whether histone acetylation levels were altered in these cell lines. Results. The comparison of CREBBP-mutated RSTS cell lines with cell lines derived from patients with an unrelated mental retardation syndrome or healthy controls revealed significant deficits in histone acetylation, affecting primarily histone H2B and histone H2A. The most severe defects were observed in the lines carrying the whole deletion of the CREBBP gene and the truncating mutation, both leading to a haploinsufficiency state. Interestingly, this deficit was rescued by treatment with an inhibitor of histone deacetylases (HDACi). Conclusions. The authors' results extend to humans the seminal observations in RSTS mouse models and point to histone acetylation defects, mainly involving H2B and H2A, as relevant molecular markers of the disease.

Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome / J.P. Lopez-Atalaya, C. Gervasini, F. Mottadelli, S. Spena, M. Piccione, G. Scarano, A. Selicorni, A. Barco, L. Larizza. - In: JOURNAL OF MEDICAL GENETICS. - ISSN 0022-2593. - 49:1(2012 Jan), pp. 66-74.

Histone acetylation deficits in lymphoblastoid cell lines from patients with Rubinstein-Taybi syndrome

C. Gervasini;F. Mottadelli;S. Spena;L. Larizza
2012-01

Abstract

Background. Rubinstein-Taybi syndrome (RSTS) is a congenital neurodevelopmental disorder defined by postnatal growth deficiency, characteristic skeletal abnormalities and mental retardation and caused by mutations in the genes encoding for the transcriptional co-activators with intrinsic lysine acetyltransferase (KAT) activity CBP and p300. Previous studies have shown that neuronal histone acetylation is reduced in mouse models of RSTS. Methods. The authors identified different mutations at the CREBBP locus and generated lymphoblastoid cell lines derived from nine patients with RSTS carrying distinct CREBBP mutations that illustrate different grades of the clinical severity in the spectrum of the syndrome. They next assessed whether histone acetylation levels were altered in these cell lines. Results. The comparison of CREBBP-mutated RSTS cell lines with cell lines derived from patients with an unrelated mental retardation syndrome or healthy controls revealed significant deficits in histone acetylation, affecting primarily histone H2B and histone H2A. The most severe defects were observed in the lines carrying the whole deletion of the CREBBP gene and the truncating mutation, both leading to a haploinsufficiency state. Interestingly, this deficit was rescued by treatment with an inhibitor of histone deacetylases (HDACi). Conclusions. The authors' results extend to humans the seminal observations in RSTS mouse models and point to histone acetylation defects, mainly involving H2B and H2A, as relevant molecular markers of the disease.
TRANSCRIPTIONAL COACTIVATOR CBP ; CREB-BINDING-PROTEIN ; LONG-TERM-MEMORY ; ACETYLTRANSFERASE ACTIVITY ; SUBMICROSCOPIC DELETIONS ; DEACETYLASE INHIBITORS ; GENETIC-HETEROGENEITY ; SYNAPTIC PLASTICITY ; MUTATIONS ; EP300
Settore MED/03 - Genetica Medica
Article (author)
File in questo prodotto:
File Dimensione Formato  
jmedgenet-2011-100354.full.pdf

accesso aperto

Tipologia: Pre-print (manoscritto inviato all'editore)
Dimensione 608.05 kB
Formato Adobe PDF
608.05 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2434/164984
Citazioni
  • ???jsp.display-item.citation.pmc??? 28
  • Scopus 54
  • ???jsp.display-item.citation.isi??? 54
social impact